Clinical applicability of current pharmacokinetic models: Splanchnic elimination of 5-fluorouracil in cancer patients
- 1 June 1988
- journal article
- conference paper
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 16 (3) , 229-249
- https://doi.org/10.1007/bf01062135
Abstract
What can be inferred from limited clinical data by using current models of hepatic elimination? We examined this question by analyzing previously published data on the steady-state uptake of the anticancer agent 5-fluorouracil (5-FU) in seven cancer patients in terms of the venous equilibration model, the undistributed and distributed forms of the sinusoidal perfusion model, and the convection-dispersion model. Because of appreciable extrasplanchnic removal of 5-FU, the value of the steady infusion rate was not used in our analysis. When the data from all patients were pooled by plotting the measured hepatic venous concentration against the measured hepatic arterial concentration, the high concentration data fell on a limiting straight line of slope 1, indicating that at high dose rates elimination of 5-FU in both the liver and gastrointestinal tract was close to saturation. The intercept of this line gave a model-independent estimate of Vmax/Q= 48.0±11.6 (SD) μM for the pooled data set, where Vmax is the maximum splanchnic elimination rate of 5-FU, and Q is the hepatic blood flow. The low concentration data points fell on a limiting straight line through the origin, from which model-dependent values of the Michaelis constant were determined. The venous equilibration model gave K m=9.4μM,while the undistributed sinusoidal perfusion model gave K m * =26,5μM. With these values of K m,both models fit the pooled data equally well. These methods were applied to analyses of the five individual data sets which contained sufficiently high concentration data points. The resulting mean values were Vmax/Q=41.0±5.1 (sem) μM,K m=8.4±1.3μM and K m * =23.2±3.2 μM. However, the splanchnic region is a highly heterogeneous organ system, for which an undistributed analysis provides no more than an upper bound on the Michaelis constant K m + (K m + ⩽K m * ).A perfusion model distributed to represent total splanchnic elimination is developed in the Appendix. Using previous estimates of the degree of functional heterogeneity in the liver alone, this model yields K m + values for individual patients which have a mean of 20.3±2.8 μM.This publication has 24 references indexed in Scilit:
- A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerationsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Pulmonary Elimination of 5-Fluorouracil in Anesthetized RatsJournal of Pharmaceutical Sciences, 1985
- A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytesBiochemical Pharmacology, 1984
- Effects of capillary heterogeneity on rates of steady uptake of substances by the intact liverMicrovascular Research, 1981
- Flow dependence of first-order uptake of substances by heterogeneous perfused organsJournal of Theoretical Biology, 1980
- Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver.1978
- Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liverAmerican Journal of Physiology-Legacy Content, 1976
- The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.1973
- The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.1972
- FACTORS AFFECTING DRUG METABOLISMAnnals of the New York Academy of Sciences, 1971